Johnson & Johnson Completes Acquisition of Cougar Biotechnology
NEW BRUNSWICK, N.J., July 10 /PRNewswire-FirstCall/ -- Johnson
(NYSE: JNJ ) today announced it has successfully completed its acquisition of Cougar Biotechnology, Inc., a development stage biopharmaceutical company with a specific focus on oncology.
Johnson & Johnson Completes Initial Tender Offer for Cougar Biotechnology
NEW BRUNSWICK, N.J., July 3 /PRNewswire-FirstCall/ -- Johnson
(NYSE: JNJ ) today announced that the initial offering period of its tender offer for all outstanding shares of common stock of Cougar Biotechnology, Inc. (Nasdaq: CGRB ) expired at midnight (Eastern time) on Ju...
Johnson & Johnson Announces Regulatory Clearance for Its Planned Acquisition of Cougar Biotechnology
NEW BRUNSWICK, N.J., June 17 /PRNewswire-FirstCall/ -- Johnson
(NYSE: JNJ ) today announced the U.S. Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act with respect to its previously announced planned ...
Johnson & Johnson Begins Tender Offer to Acquire Cougar Biotechnology
NEW BRUNSWICK, N.J., June 5 /PRNewswire-FirstCall/ -- Johnson
(NYSE: JNJ ), through a new wholly-owned subsidiary, Kite Merger Sub, Inc., today will commence a cash tender offer to purchase all outstanding shares of common stock of Cougar Biotechnology, Inc. (Nasdaq: CGRB ). Joh...
Johnson & Johnson Announces Definitive Agreement to Acquire Cougar Biotechnology, Inc.
Access to Late-Stage, First-in-Class Prostate Cancer Treatment Strengthens Presence in Oncology
NEW BRUNSWICK, N.J., and LOS ANGELES, May 21 /PRNewswire-FirstCall/ -- Johnson
(NYSE: JNJ ) and Cougar Biotechnology, Inc. (Nasdaq: CGRB ), a development stage biopharmaceutical c...
Simbionix and Johnson & Johnson LLC Announce a Distribution Agreement for Russia and the CIS Countries
CLEVELAND, Ohio, April 17 /PRNewswire/ -- Simbionix, the world's leading
developer of medical simulation systems, today announced an agreement with
Johnson & Johnson
LLC for distribution of Simbionix's simulators and related
LLC, a subsidiary of Johns...
Burnham Announces Assay Development and License Agreement with Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
LA JOLLA, Calif., Jan. 13 /PRNewswire/ -- Burnham Institute for Medical Research (Burnham) has signed an assay development and license agreement with Johnson
Pharmaceutical Research and Development, L.L.C. (J&JPRD). The agreement is Burnham's first broad-based partnership with a...
Johnson & Johnson Completes Acquisition of Omrix Biopharmaceuticals, Inc.
NEW BRUNSWICK, N.J., Dec. 30 /PRNewswire-FirstCall/ -- Johnson
(NYSE: JNJ ) today announced the completion of its previously announced acquisition of Omrix Biopharmaceuticals, Inc., a fully-integrated biopharmaceutical company that develops and markets biosurgical and immunotherapy...
Johnson & Johnson Announces Definitive Agreement to Acquire Omrix
Omrix's Biopharmaceutical Expertise Complements ETHICON's Industry-Leading Surgery Portfolio
NEW BRUNSWICK, N.J. and NEW YORK, Nov. 24 /PRNewswire-FirstCall/ -- Johnson
(NYSE: JNJ ) and Omrix Biopharmaceuticals, Inc. (Nasdaq: OMRI ), a fully integrated biopharmaceutical...
Cynvec LLC(SM) Appoints Former Johnson & Johnson Executive Frank D. Stonebanks as President and Chief Executive Officer
NEW YORK, Nov. 11 /PRNewswire/ -- Cynvec LLC, a privately-held
biopharmaceutical company focused on developing novel cancer therapies that
harness the apoptotic ability of the Sindbis viral vector, announced today
that it has appointed Frank D. Stonebanks President and Chief Executive
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Submits New Drug Application to FDA for Carisbamate
Seeks Approval for Use in Epilepsy as Adjunctive Treatment in Partial Onset Seizures
RARITAN, N.J., Oct. 24 /PRNewswire/ -- Johnson
Research & Development, L.L.C. (J&JPRD) announced today that it has
submitted a New Drug Application to the ...
Sustainable Oils Names Scott Johnson as General Manager, Expands Management Team for Camelina Research and Production
BOZEMAN, Mont., Oct. 20 /PRNewswire/ -- Sustainable Oils has named a
leading agricultural chemical, seed, and biotechnology industry
professional as the company's general manager. Scott Johnson
responsible for the company's continuing efforts to build camelina
production and marketing ...
Johnson & Johnson Honors 2008 Recipients of The Dr. Paul Janssen Award for Biomedical Research
Feldmann and Maini Honored for Discovery of New Class of Anti-Inflammatory Drugs
BEERSE, Belgium, Sept. 10 /PRNewswire/ -- The 2008 recipients of The
Dr. Paul Janssen Award for Biomedical Research, Professor Marc Feldmann,
FMedSci, FAA, FRS and Emeritus Professor...
Craig Johnson Joins Ardea Biosciences' Board of Directors
SAN DIEGO, June 12 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc.
(Nasdaq: RDEA ) today announced the appointment of Craig Johnson
Company's Board of Directors.
"We are pleased to welcome Mr. Johnson
to Ardea as an independent
member of our Board of Directors," said Barry D. Quart...
Ortho Biotech Oncology Research & Development Unites Johnson & Johnson Biopharmaceutical Oncology R&D Assets
SAN DIEGO, California, April 11 /PRNewswire/ --
- Newly Established Organization Presents Data on Advancing Compounds
at AACR -
Ortho Biotech Oncology Research & Development (ORD), a unit of Johnson
Pharmaceutical Research & Development, L.L.C., will announce
results from studies...
MultiVu Video Feed: Johnson & Johnson Diabetes Institute, LLC Launches New Training Center to Improve Community-Based Diabetes Care
Training Center Scheduled to Open Friday, Feb. 29
On Friday, February 29, the Johnson
Diabetes Institute, LLC
will open its first training center in the U.S., designed to improve how
practitioners deliver diabetes care in local communities. Located in
Milipitas, CA, the center will...
Two-time Defending NASCAR Sprint Cup Series Champion Jimmie Johnson Joins the Team at CORD:USE Cord Blood Bank to Help Win the Race for Life
DAYTONA BEACH, Fla., Feb. 12 /PRNewswire/ -- CORD:USE Cord Blood Bank
is proud to announce that two-time defending NASCAR Sprint Cup Series
Champion Jimmie Johnson
has joined its team. "We're honored to have this
NASCAR superstar and terrific person on our team," states Dr. Edward
Drugs from Johnson & Johnson/Basilea and Forest Are the Most Promising Antibiotics in the Community-Acquired Pneumonia Pipeline
Vaccines from Wyeth and GlaxoSmithKline Will Also Be Vying to Capture
Shares of the Escalating Pneumococcal Vaccine Market, According to a New Report from Decision Resources
WALTHAM, Mass., Nov. 19 /PRNewswire/ -- Decision Resources, one of the
world's leading research a...
Johnson & Johnson Announces Changes to Accelerate Growth
Three New Units to Focus on Convergence and New Opportunities
NEW BRUNSWICK, N.J., Nov. 15 /PRNewswire-FirstCall/ -- Johnson
Johnson today announced a series of organizational changes to sharpen its
focus on opportunities outside its traditional areas of interest and in the
Entry of Biogenerics and Decreasing Use of Amgen's Epogen and Johnson & Johnson's Procrit Will Cause a $2.8 Billion Decline in the Drug Market for Chemotherapy-Induced Anemia by 2016
Upheaval is Forecasted for the Markets of Five Chemotherapy Side Effect Indications, According to a New Report from Decision Resources
WALTHAM, Mass., Oct. 29 /PRNewswire/ -- Decision Resources, one of the
world's leading research and advisory firms for pharmaceutical and
Morria Biopharmaceuticals Plc Appoints Dr. Johnson Lau and Dr. David Sidransky to Board of Directors
LONDON, Sept. 25 /PRNewswire/ -- Morria Biopharmaceuticals Plc, a
private biopharmaceutical company focusing on first-in-class, novel
non-steroidal anti-inflammatory drugs, today announced it has appointed Dr.
Johnson Lau and Dr. David Sidransky to its board of directors. Dr. Johnson
Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
VANCOUVER, Sept. 17 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals,
Inc. (NASDAQ: ANPI , TSX: ANP), announced today that it reached a favourable
agreement with Johnson
& Johnson's subsidiary, Conor Medsystems ("Conor")
to settle all outstanding patent litigation with respect to Conor's
Legendary Earvin 'Magic' Johnson Joins AFL/Signalife Cardiovascular Protection Team
LOS ANGELES, Sep. 6 /PRNewswire-FirstCall/ -- Signalife, Inc. (Amex:
SGN) has announced that the legendary Earvin "Magic" Johnson
Athletes for Life ("AFL") to endorse ambulatory heart testing with AFL's
flagship choice, Signalife's Fidelity 100 and its related products and
Tennessee health care system to install Johnson Controls wireless tech
MILWAUKEE The Mountain States Health Alliance , a regional health care system in northeast Tennessee, has signed an agreement with the Milwaukee-based Johnson
Controls, Inc. , for system-wide installation of a wireless distribution technology.
The InnerWireless System will be installed throug...
Tech Digest: Fiserv, Conjugon, Johnson Controls
Fiserv in talks with Australian banks
Brookfield, Wis. Check-processing firm Fiserv is in negotiations with three major Australian banks Commonwealth Bank of Australia, National Australia Bank and Westpac Banking Corporation to manage the Vipro check processing system. If negotiations are...
Tech Digest: Johnson Controls, Urban League Johnson
Controls to sell French engine electronics business
Controls plans to sell its engine electronics business to Valeo, a French company that will pay approximately 330 million Euros, or $430 million in today's dollars. The business is headquartered in Pontoise, Franc...
Tech Digest: Modine, Johnson Controls profits; iPods; FBI
Modine profits climb
Racine-based Modine Manufacturing made $18.9 million in fourth-quarter 2004, compared to $12.3 million a year before that. Improved sales, as well as favorable currency-exchange rates, drove the increase. Its revenue was $418.4 million.
The company makes heat-management...
Tech Digest: UWM technologist leaving; Banta, API, Johnson Controls
University of Wisconsin-Milwaukee The director of the university's Center for Intelligent Maintenance Systems said last week he would leave for the University of Cincinnati in April. Professor Jay Lee told the Milwaukee Journal-Sentinel that he did not feel valued, and that UW-Milwaukee does ...
Memphis hospital group installing Johnson Controls wireless infrastructure
Baptist Memorial Health Care in Memphis, Tenn., will install a wireless distribution infrastructure at five of its largest hospitals and the organization's corporate office under a $6 million agreement with Glendale, Wis.-based Johnson
The wireless distribution system will provide ...
S.C. Johnson lands in No. 2 spot in Information Week 500 list
Racine, Wis. - S.C. Johnson
& Son Inc. made the No. 2 spot in the Information Week 500 , up from 95 th place in 2004. The top spot in this year's list of technology innovators went to Capital One.
Seven other Wisconsin organzations, other than S.C. Johnson, made this year's list.
Bush praises Johnson Controls battery tech in Milwaukee visit
Milwaukee, Wis. President George Bush today spoke of energy during a visit to Wisconsin, but rather than concentrate on traditional energy resources, his remarks were directed toward new methods of treating what he called the nation's addiction to foreign oil.
In an address before employees a...
Research park adds Johnson Controls, Eaton
Wauwatosa, Wis. - Two of the largest U.S.-based multi-national corporations have decided to lease space in the Milwaukee County Research Park .
Controls and Eaton Corp. will have sales offices in the park, according to Dave Domres, vice president of asset management for Irgens De...
SC Johnson issues trademark warning over web offer
Racine, Wis. - SC Johnson
has issued a cease-and-desist letter for the website FreeShowerCleaner.com, a site that allegedly uses imagery of SC Johnson
products for spam purposes.
FreeShowerCleaner.com, which lists a postal address in Carlisle, Pennsylvania, offers a free Scrubbing Bubbles Au...
Florida schools employ Johnson Controls technology to stop sex predators
Milwaukee, Wis. - The nation's fifth largest school district is being outfitted with a new security system designed by Johnson
Controls, Inc. , to deter sexual predators from entering school grounds.
Johnson Controls, known more for its attempts to develop hybrid car batteries and energy-effi...
Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
...numerically lower incidences of repeat procedures to treat restenosis at two years as compared to patients treated with 'olimus-based DES's, including johnson
Johnson, Inc.'s Cypher(R) Stent and Medtronic Inc.'s Endeavor(R) Stent.
In the patients with diabetes, the TAXUS Liberte demonstrated a statistica...
Shire plc: Core Portfolio of Products Delivers 20% Sales Growth
...exclusive marketing rights) by
Janssen Pharmaceutical N.V., an affiliate of johnson
of the REMINYL/RAZADYNE range continue to grow in most c...
Cephalon Appoints Craig C. Phillips as Vice President and General Manager of Oncology Business Unit
...n Oncology portfolio. Prior to joining Cephalon, Phillips spent 15 years at johnson
and has more than 22 years of pharmaceutical industry experience.
IIVS Announces Initiation by EPA of a Pilot Program to Evaluate Non-Animal Eye-Irritation Methods
...consumer product companies - The Procter & Gamble Company, Clorox, Colgate Palmolive, The Dial Corporation, Ecolab, JohnsonDiversey, Inc. and S.C. johnson
& Son, Inc. - provided data from in vitro as well as previously conducted animal studies on more than 300 representative cleaning products. IIVS...
Marinus Pharmaceuticals Adds Two Life Sciences Veterans to its Board of Directors
...on. He has served on the boards of directors of over 20 public and private entrepreneurial companies, including Cell Pathways, OraPharma (acquired by johnson
& Johnson), National MD (acquired by GE), OmniSonics, GenVec, CardioNet and Spine Wave. Rein also serves as a Trustee of the Cleveland Clinic, Cha...
NASA Extends Bioastronautics Contract With Wyle for Total Value of $976 Million
...provide continuing support to the Space Life Sciences Directorate at NASA's johnson
Space Center. The option extends the contract to April 30, 2013. The work ...d and no longer supported.
The majority of the work is performed at johnson
Space Center. Work also is performed at launch and landing sites in the Uni...